Company News: Page (1) of 1 - 02/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Sun Pharma Announces Twelve Tildrakizumab Abstracts to be Presented at American Academy of Dermatology 2018 Annual Meeting

Data Presentations Highlighting Pivotal Phase 3 Trial Analyses on Long-Term Safety, One-Year Efficacy and Pre-Treated Patients will Offer Further Insights on the Potential of the Investigational IL-23... (February 12, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Pro AV,Post/Production,Management,Presentors,Management,Prosumer/Consumer,Business,Business Issues,Presentation,People,Events,USA, Inc.,Medicine,Disease,healthcare,Surgery,Science,Medical,Business,Other,

-->

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved